– First to offer suite of tests in easy to access format for children with developmental disabilities – SAN FRANCISCO, April 4, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics ...
RESEARCH TRIANGLE PARK – Invitae, a California-based medical genetics company that will soon open a new laboratory and production facility in Morrisville, has commercially launched a new testing ...
Invitae is boosting its neurology and cardiology diagnostic test offerings. The San Francisco-based company will be adding 11 panels for heritable diseases and will update 17 existing neurology panels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results